honokiol has been researched along with Lung Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (15.63) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 10 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Lin, JM; Prakasha Gowda, AS; Sharma, AK | 1 |
| Chen, K; Chen, L; Fu, S; Li, D; Liu, Z; Peng, A; Tang, H; Tang, M; Wan, L; Xue, L; Ye, H; Zhang, Y | 1 |
| Jiang, D; Liu, J; Liu, X; Pan, Y; Qiu, Y; Shi, Y; Wan, H; Wang, P; Ying, K; Zhu, Y | 1 |
| Du, K; Jia, Y; Li, Y; Liu, Y; Luo, Y; Wang, B; Wang, Z; Yang, J; Yang, S; Zhu, B | 1 |
| Chen, T; Cheng, X; Fan, L; Huang, Y; Qiao, Y; Shen, X; Wang, F; Wei, M; Yu, D | 1 |
| Mu, HJ; Sun, YL; Wang, J; Wang, Y; Yuan, B | 1 |
| Li, M; Mei, M; Tang, L; Xue, N; Zhou, H | 1 |
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
| Arbiser, J; Fan, S; Owonikoko, TK; Qian, G; Ramalingam, SS; Sun, SY; Zang, H | 1 |
| Chen, W; Jin, X; Li, F; Li, H; Li, Q; Liu, B | 1 |
| Chen, CG; Jiang, Q; Li, J; Li, XQ; Long, WG; Ren, J; Su, JY; Wang, Y; Zhu, YM | 1 |
| Chen, Y; Hu, X; Li, J; Li, Y; Qu, J; Wang, D; Wang, Z; Xia, M; Yuan, R; Zhang, H; Zhang, Y | 1 |
| Krahn, MP; Kullmann, L | 1 |
| Cheng, L; Fu, M; Ju, RJ; Li, XT; Liu, JJ; Wang, X; Xiao, Y; Xie, HJ | 1 |
| Bao, Z; Cen, M; Cui, L; Fang, L; Lu, G; Yang, G; Yao, Y; Zhou, J | 1 |
| Feng, J; Gao, W; Xu, S; Zhao, G; Zhu, J | 1 |
| Deng, S; Ma, L; Yang, L; Zhang, C | 1 |
| Ding, Z; Fu, R; Shen, W; Wan, Y; Zhang, J; Zhang, Y; Zhen, Y | 1 |
| Chen, SZ; Li, Y; Shang, Y; Wang, WD | 1 |
| Katiyar, SK; Singh, T | 1 |
| Kalyanaraman, B; Komas, SM; Liu, Q; Lubet, RA; Pan, J; Wang, Y; You, M; Zhang, Q | 1 |
| Anandharaj, A; Hong, KH; Kassie, F; Kim, JH; Kirtane, AR; Panyam, J; Song, JM; Upadhyaya, P | 1 |
| Chen, SZ; Lv, XQ; Qiao, XR; Su, L | 1 |
| Ahmad, A; Arora, S; Averett, C; Bhardwaj, A; Carter, JE; Khan, MA; Khushman, M; Singh, AP; Singh, S; Srivastava, SK | 1 |
| Lee, Y; Pan, J; Wan, TC; Wang, Y; Xiong, D; You, M; Zhang, Q | 1 |
| Acker, TM; Arbiser, JL; Chen, S; Khuri, FR; Lefkove, B; Raja, SM; Sun, SY; Yue, P | 1 |
| Chen, LJ; Fan, LY; Guo, WH; Hou, WL; Jiang, QQ; Wei, YQ; Yang, GL | 1 |
| Chen, L; Fu, S; Gong, C; Gou, M; Men, K; Qian, Z; Qiu, L; Shi, S; Wei, X; Zeng, S; Zheng, X | 1 |
| Chen, LJ; Chen, PL; Chen, X; Hou, WL; Hu, J; Liu, L; Tang, MH; Wang, XH; Wei, YQ; Yang, G; Zhang, F; Zhao, X | 1 |
| Gong, C; Guo, G; Luo, F; Mao, Y; Qian, Z; Wang, X; Wang, Y; Wei, X | 1 |
| Arbiser, J; Arlt, MJ; Banke, IJ; Born, W; Fuchs, B; Langsam, B; Muff, R; Steinmann, P; Walters, DK; Ziegler, U | 1 |
| Hsieh, MT; Hsu, SL; Tsai, TH; Yang, SE | 1 |
2 review(s) available for honokiol and Lung Neoplasms
| Article | Year |
|---|---|
Use of honokiol in lung cancer therapy: a mini review of its pharmacological mechanism.
Topics: Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Lignans; Lung Neoplasms; Signal Transduction | 2023 |
Controlling the master-upstream regulation of the tumor suppressor LKB1.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Biphenyl Compounds; Calcium-Binding Proteins; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lignans; Lung Neoplasms; Lysosomes; Mutation; Peutz-Jeghers Syndrome; Phosphorylation; Protein Serine-Threonine Kinases; Sumoylation; Ubiquitination | 2018 |
30 other study(ies) available for honokiol and Lung Neoplasms
| Article | Year |
|---|---|
In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Lignans; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship | 2012 |
Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Lung Neoplasms; Magnolia; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2018 |
A multidimensional biosensor system to guide LUAD individualized treatment.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biosensing Techniques; Biphenyl Compounds; Cell Culture Techniques; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lignans; Lung Neoplasms; Male; Mice; Mice, Nude; Piperidines; Precision Medicine; Quinazolines; Tumor Cells, Cultured | 2021 |
PCAT19 Regulates the Proliferation and Apoptosis of Lung Cancer Cells by Inhibiting miR-25-3p via Targeting the MAP2K4 Signal Axis.
Topics: Animals; Anisomycin; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lignans; Lung Neoplasms; MAP Kinase Kinase 4; Mice; Mice, Nude; MicroRNAs; RNA, Long Noncoding | 2022 |
Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Human Umbilical Vein Endothelial Cells; Humans; Interleukins; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2023 |
Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
Topics: Animals; Cell Line, Tumor; Humans; Lung Neoplasms; Macrophages; Mice; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.
Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Humans; Lignans; Lung Neoplasms; Mice, Nude; Mutation; Protein Kinase Inhibitors | 2020 |
Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carbon; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Breaks, Double-Stranded; G2 Phase Cell Cycle Checkpoints; Humans; Ions; Lignans; Linear Energy Transfer; Lung Neoplasms; Protein Kinase Inhibitors; Radiation Tolerance; Radiation-Sensitizing Agents; Thiophenes; Tunicamycin; Urea; X-Rays | 2020 |
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
Topics: Animals; Apoptosis; Biphenyl Compounds; Calcium; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Lignans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mitochondria; Paclitaxel; Proteasome Endopeptidase Complex; Ubiquitin-Activating Enzymes; Vacuoles | 2021 |
Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrogen-Ion Concentration; Lignans; Lipids; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles | 2021 |
Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Survival; Dequalinium; Drug Interactions; Drug Liberation; Humans; Lignans; Lung Neoplasms; Mice; Micelles; Neoplasm Metastasis; Paclitaxel; Temperature; Xenograft Model Antitumor Assays | 2018 |
Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Fibroblast Growth Factor 2; Humans; Lignans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Receptor, Fibroblast Growth Factor, Type 1 | 2018 |
Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells.
Topics: A549 Cells; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Lignans; Lung Neoplasms; RNA, Small Interfering; Signal Transduction; Transcription Factor CHOP | 2019 |
Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Proliferation; Female; Formates; Humans; Lignans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Topics: A549 Cells; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lignans; Lung Neoplasms; MicroRNAs; Principal Component Analysis; RNA, Messenger | 2019 |
Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; Lignans; Lung Neoplasms; Mice, Inbred BALB C; Snail Family Transcription Factors | 2019 |
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
Topics: beta Catenin; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drugs, Chinese Herbal; Gene Knockdown Techniques; Humans; Lignans; Lung Neoplasms; Neoplasm Invasiveness; RNA Interference; Signal Transduction; Sulfonamides; Transcription Factor RelA | 2013 |
Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
Topics: Adenosine Triphosphate; Animals; Anticarcinogenic Agents; Apoptosis; Biphenyl Compounds; Bronchi; Carcinogens; Carcinoma, Squamous Cell; Carmustine; Caspase 3; Caspase 7; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Lignans; Lung Neoplasms; Mice; Mitochondria; Neoplasm Transplantation; Oxidation-Reduction; Reactive Oxygen Species | 2014 |
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Assay; Biphenyl Compounds; Bronchi; Carcinogenesis; Cell Cycle; Cell Proliferation; Cell Survival; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Lignans; Lung Neoplasms; Magnolia; Mice; Molecular Docking Simulation; Nitrosamines; Plant Extracts; RNA, Small Interfering | 2016 |
Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Lignans; Lung Neoplasms | 2016 |
Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Communication; Cell Line, Tumor; Down-Regulation; Female; Gene Expression; Hedgehog Proteins; Humans; Lignans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Pancreatic Neoplasms; Receptors, CXCR4; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Lignans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred NOD; Mice, SCID; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Topics: Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Lignans; Lung Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Receptors, Death Domain; TNF-Related Apoptosis-Inducing Ligand; Ubiquitin | 2008 |
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Humans; In Situ Nick-End Labeling; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Platelet Endothelial Cell Adhesion Molecule-1 | 2008 |
Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line, Tumor; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Humans; Lasers; Lignans; Lung Neoplasms; Micelles; Microscopy, Atomic Force; Particle Size; Polyesters; Polyethylene Glycols; Temperature | 2009 |
Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Humans; Lignans; Liposomes; Lung Neoplasms; Magnolia; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Radiation Tolerance; Transplantation, Heterologous | 2008 |
Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drug Stability; Drugs, Chinese Herbal; Humans; Lignans; Lung Neoplasms; Mice; Micelles; Microscopy, Electron, Transmission; Particle Size; Polyesters; Polyethylene Glycols; Solubility; Sonication; X-Ray Diffraction | 2010 |
Antimetastatic activity of honokiol in osteosarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Bone Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Lignans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred C3H; Osteosarcoma | 2012 |
Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Biphenyl Compounds; Caspases; Cytochrome c Group; Enzyme Activation; Humans; Lignans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2002 |